In this Issue:
In our most recent medicine review we look at one of the novel anticoagulants recently
subsidised for use in Australia. With more treatment choices for NVAF available, Research Review
has compiled a summary of the supporting evidence for this medicine.
Also included is some guiding independent commentary from Associate Professor John Amerena.
Please login below to download this issue (PDF)